Loading…
Based on limited metadata, the FDA issued a Warning Letter to Puget Sound Drug Corporation, operating as Key Pharmacy and Compounding Center, on April 4, 2018. The letter addresses violations related to a pharmacy compounding operation, though the specific nature of the violations cannot be determined without access to the full letter text. The regulatory action falls under FDA oversight of compounding pharmacies, which are subject to standards for pharmaceutical manufacturing and quality control. Additional details regarding the specific violations and regulatory requirements cited would require review of the complete Warning Letter.